Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used

被引:10
作者
Anderegg, TR
Jones, RN
Sader, HS
机构
[1] JMI Labs Inc, Jones Grp, N Liberty, IA 52317 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1128/JCM.42.7.3356-3358.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BAL9141 is a novel cephalosporin with a broad spectrum of activity, including activity against methicillin-resistant staphylococci. This multicenter study was performed to establish quality control (QC) guidelines for susceptibility testing of BAL9141 in phase 3 clinical trials and after U.S. Food and Drug Administration approval. The proposed 3 or 4 log, dilution MIC ranges encompass 97.8 to 100.0% of reported results, while the proposed 7- to 9-mm-zone-diameter QC ranges included 95.2 to 99.4% of the participant-reported disk diffusion results.
引用
收藏
页码:3356 / 3358
页数:3
相关论文
共 12 条